Science. Supply Chain. Certainty.
Cryoportal Login Request a Quote Menu

Clinical Trials LogisticsThe Chain of Compliance® - Contract Pharma

The Chain of Compliance® - Contract Pharma

June 14, 2018

Chain of Compliance® is vital for the Regenerative Medicine Advanced Therapy (RMAT) market which presents a major opportunity for the industry. In a recent Contract Pharma article, Mark W. Sawicki, Ph.D., Chief Commercial officer of Cryoport, discusses why the Chain of Compliance® is critical to winning in the RMAT market.  Read more >

Questions or comments? We welcome your feedback!

Email Us

Tags: Clinical Trials Logistics, Temperature Controlled Logistics, Chain of Compliance®

Request a Quote
Free White Paper
Advanced Therapy Shipper

A Leap Forward in Standardizing the Regenerative Medicine Supply Chain – What the New ISO 21973 Guidance Means for Cell and Gene Therapy Developers

Download Now
  • Are you prepared for 2022’s Data Management Transition?
    •

    Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC